EBS vs STZ · rev $390.4M vs P/E 14, rev $9.14B
Emergent Biosolutions Inc (EBS) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported EBS revenue for 2026-06-30 was $390.4M. Net income was -$173.4M. EBS currently screens at market cap $416.4M.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
EBS currently screens at market cap $416.4M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the EBS and STZ stock pages for the full models.
Not investment advice.